Pharmaceutical company funding and its consequences: A qualitative systematic review

This publication has 26 references indexed in Scilit:

• Association of Industry Sponsorship to Published Outcomes in Gastrointestinal Clinical Research
  Clinical Gastroenterology and Hepatology, 2006
• Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review
  BMJ, 2006
• A meta-analysis comparing trials of antimuscarinic medications funded by industry or not
  BJU International, 2006
• Bias from industry trial funding? A framework, a suggested approach, and a negative result
  Pain, 2006
• Relationship between drug company funding and outcomes of clinical psychiatric research
  Psychological Medicine, 2006
• Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
  American Journal of Psychiatry, 2006
• Money, Method and Medical Research
  Episteme, 2004
• Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: A re-examination
  The British Journal of Psychiatry, 2003
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996
• A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis
  Archives of internal medicine (1960), 1994